文献速递产科

实施基于问题的产前物质使用筛查后新生儿药物检测中的种族差异

Racial Disparities in Newborn Drug Testing After Implementation of Question-Based Screening for Prenatal Substance Use.
PubMed 文献 · Obstet Gynecol · 2024-06-06

本研究为回顾性队列研究,纳入美国中西部学术医疗中心2014至2022年间32,802例活产,比较2018年实施基于问题的筛查前后产前和新生儿药物检测的变化。结果显示筛查实施后产前尿液检测订单下降(5.0% vs 3.1%,P<.001),黑人分娩父母降幅最大(10.3% vs 4.9%),但新生儿药物检测率无变化(4.7% vs 4.5%,P=.46),且黑人分娩父母的新生儿仍被开具更多检测。结论认为筛查未改变新生儿检测的种族不平等。

要点

  • 基于问题的产前物质使用筛查实施后,产前尿液药物检测订单从5.0%降至3.1%(P<.001)。
  • 黑人分娩父母的产前尿液检测降幅最大,从10.3%降至4.9%。
  • 新生儿药物检测率整体无变化(4.7% vs 4.5%,P=.46),黑人新生儿仍被更多检测。

核心结论

  • 实施基于问题的孕期物质使用筛查与产前尿液药物检测减少相关,但新生儿药物检测总体率及黑人分娩父母新生儿检测的种族不平等未改变。
  • 作者认为需要进一步的政策努力来改善物质使用治疗并消除新生儿药物检测及后续儿童保护服务报告等惩罚性政策中的种族不平等。

研究设计与样本

  • 回顾性队列研究,纳入美国中西部一家学术医疗中心2014年至2022年间32,802例活产。
  • 比较2018年实施基于问题的筛查前后,主要结局为产前和新生儿药物检测订单。
  • 采用广义估计方程框架的logistic回归模型评估筛查与结果、分娩父母年龄、种族、族裔、婚姻状况和保险类型的关联。
  • 对表示难以停止物质使用的患者病历进行审计以评估指南导向的照护。

主要发现

  • 14,992名孕妇中12,725名(85.3%)接受了基于问题的筛查。
  • 产前尿液检测订单从实施前的5.0%(95%CI 4.6-5.3%)降至实施后的3.1%(95%CI 2.8-3.4%),P<.001。
  • 黑人分娩父母的产前尿液药物检测从实施前的10.3%(95%CI 9.0-11.7%)降至实施后的4.9%(95%CI 3.9-5.9%)。
  • 新生儿药物检测率无变化:实施前4.7%(95%CI 4.4-5.0%),实施后4.5%(95%CI 4.2-4.8%),P=.46。
  • 临床医生仍为黑人分娩父母的新生儿开具显著多于其他种族和族裔群体的新生儿药物检测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the association of universal question-based screening for prenatal substance use on racial inequities in prenatal and newborn drug testing. METHODS: We conducted a retrospective cohort study of 32,802 live births of patients receiving prenatal care at an academic medical center in the midwestern United States from 2014 to 2022, before and after implementation of question-based screening in 2018. Primary outcomes included prenatal and newborn drug test orders. Logistic regression models using a generalized estimating equation framework assessed associations with question-based screening and results, birthing parent age, race, ethnicity, marital status, and insurance type. Charts of patients who indicated difficulties stopping substance use were audited for guideline-directed care. RESULTS: A total of 12,725 of 14,992 pregnant people (85.3%) received question-based screening. Implementation of question-based screening was associated with a decrease in prenatal urine test orders (5.0% [95% CI, 4.6-5.3%] before implementation, 3.1% [95% CI, 2.8-3.4%] after implementation; P <.001), with Black birthing parents having the largest reduction in prenatal urine drug testing (10.3% [95% CI, 9.0-11.7%] before implementation, 4.9% [95% CI, 3.9-5.9%] after implementation). However, rates of newborn drug testing did not change (4.7% [95% CI, 4.4-5.0%] before implementation, 4.5% [95% CI, 4.2-4.8%] after implementation; P =.46), and clinicians continued to order significantly more newborn drug tests for newborns of Black birthing parents compared with other race and ethnicity groups. CONCLUSION: Implementation of question-based screening for substance use in pregnancy was associated with decreased prenatal urine drug testing but no change in overall newborn drug testing or racial inequities in newborn drug testing for Black birthing people. Further policy efforts are warranted to improve substance use treatment and to eliminate racial inequities in punitive policies such as newborn drug testing and subsequent child protective services reporting.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Soos A, Plegue M, Darwiche A, et al. Racial Disparities in Newborn Drug Testing After Implementation of Question-Based Screening for Prenatal Substance Use. Obstet Gynecol. 2024. PMID: 38843536. doi:10.1097/AOG.0000000000005631

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。